These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

345 related articles for article (PubMed ID: 32690435)

  • 21. Current Status of Cardiac Regenerative Therapy Using Induced Pluripotent Stem Cells.
    Sugiura T; Shahannaz DC; Ferrell BE
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38891960
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The electrophysiological development of cardiomyocytes.
    Liu J; Laksman Z; Backx PH
    Adv Drug Deliv Rev; 2016 Jan; 96():253-73. PubMed ID: 26788696
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Universal and Robust Integrated Platform for the Scalable Production of Human Cardiomyocytes From Pluripotent Stem Cells.
    Fonoudi H; Ansari H; Abbasalizadeh S; Larijani MR; Kiani S; Hashemizadeh S; Zarchi AS; Bosman A; Blue GM; Pahlavan S; Perry M; Orr Y; Mayorchak Y; Vandenberg J; Talkhabi M; Winlaw DS; Harvey RP; Aghdami N; Baharvand H
    Stem Cells Transl Med; 2015 Dec; 4(12):1482-94. PubMed ID: 26511653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Functional integration of electrically active cardiac derivatives from genetically engineered human embryonic stem cells with quiescent recipient ventricular cardiomyocytes: insights into the development of cell-based pacemakers.
    Xue T; Cho HC; Akar FG; Tsang SY; Jones SP; Marbán E; Tomaselli GF; Li RA
    Circulation; 2005 Jan; 111(1):11-20. PubMed ID: 15611367
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrigel Mattress: A Method for the Generation of Single Contracting Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes.
    Feaster TK; Cadar AG; Wang L; Williams CH; Chun YW; Hempel JE; Bloodworth N; Merryman WD; Lim CC; Wu JC; Knollmann BC; Hong CC
    Circ Res; 2015 Dec; 117(12):995-1000. PubMed ID: 26429802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Human cardiomyocyte generation from pluripotent stem cells: A state-of-art.
    Talkhabi M; Aghdami N; Baharvand H
    Life Sci; 2016 Jan; 145():98-113. PubMed ID: 26682938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pluripotent stem cell-derived cardiomyocytes for treatment of cardiomyopathic damage: Current concepts and future directions.
    Garbern JC; Escalante GO; Lee RT
    Trends Cardiovasc Med; 2021 Feb; 31(2):85-90. PubMed ID: 31983535
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Arrhythmogenicity Test Based on a Human-Induced Pluripotent Stem Cell (iPSC)-Derived Cardiomyocyte Layer.
    Slotvitsky M; Tsvelaya V; Frolova S; Dementyeva E; Agladze K
    Toxicol Sci; 2019 Mar; 168(1):70-77. PubMed ID: 30388253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Robust Cardiac Regeneration: Fulfilling the Promise of Cardiac Cell Therapy.
    Selvakumar D; Clayton ZE; Chong JJH
    Clin Ther; 2020 Oct; 42(10):1857-1879. PubMed ID: 32943195
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cellular heterogeneity of pluripotent stem cell-derived cardiomyocyte grafts is mechanistically linked to treatable arrhythmias.
    Selvakumar D; Clayton ZE; Prowse A; Dingwall S; Kim SK; Reyes L; George J; Shah H; Chen S; Leung HHL; Hume RD; Tjahjadi L; Igoor S; Skelton RJP; Hing A; Paterson H; Foster SL; Pearson L; Wilkie E; Marcus AD; Jeyaprakash P; Wu Z; Chiu HS; Ongtengco CFJ; Mulay O; McArthur JR; Barry T; Lu J; Tran V; Bennett R; Kotake Y; Campbell T; Turnbull S; Gupta A; Nguyen Q; Ni G; Grieve SM; Palpant NJ; Pathan F; Kizana E; Kumar S; Gray PP; Chong JJH
    Nat Cardiovasc Res; 2024 Feb; 3(2):145-165. PubMed ID: 39196193
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Engineered heart tissue models from hiPSC-derived cardiomyocytes and cardiac ECM for disease modeling and drug testing applications.
    Goldfracht I; Efraim Y; Shinnawi R; Kovalev E; Huber I; Gepstein A; Arbel G; Shaheen N; Tiburcy M; Zimmermann WH; Machluf M; Gepstein L
    Acta Biomater; 2019 Jul; 92():145-159. PubMed ID: 31075518
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Engineered Maturation Approaches of Human Pluripotent Stem Cell-Derived Ventricular Cardiomyocytes.
    Ge F; Wang Z; Xi JJ
    Cells; 2019 Dec; 9(1):. PubMed ID: 31861463
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cardiac regeneration with pluripotent stem cell-derived cardiomyocytes and direct cardiac reprogramming.
    Sadahiro T
    Regen Ther; 2019 Dec; 11():95-100. PubMed ID: 31304202
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cardiac regeneration using pluripotent stem cells--progression to large animal models.
    Chong JJ; Murry CE
    Stem Cell Res; 2014 Nov; 13(3 Pt B):654-65. PubMed ID: 25087896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Biowire platform for maturation of human pluripotent stem cell-derived cardiomyocytes.
    Sun X; Nunes SS
    Methods; 2016 May; 101():21-6. PubMed ID: 26546730
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cardiomyocytes derived from pluripotent stem cells: progress and prospects from China.
    Yang HT; Zhang M; Huang J; Liang H; Zhang P; Boheler KR
    Exp Cell Res; 2013 Jan; 319(2):120-5. PubMed ID: 23022397
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic transplantation of iPS cell-derived cardiomyocytes regenerates primate hearts.
    Shiba Y; Gomibuchi T; Seto T; Wada Y; Ichimura H; Tanaka Y; Ogasawara T; Okada K; Shiba N; Sakamoto K; Ido D; Shiina T; Ohkura M; Nakai J; Uno N; Kazuki Y; Oshimura M; Minami I; Ikeda U
    Nature; 2016 Oct; 538(7625):388-391. PubMed ID: 27723741
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients.
    Zwi-Dantsis L; Huber I; Habib M; Winterstern A; Gepstein A; Arbel G; Gepstein L
    Eur Heart J; 2013 Jun; 34(21):1575-86. PubMed ID: 22621821
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human pluripotent stem cell-based approaches for myocardial repair: from the electrophysiological perspective.
    Poon E; Kong CW; Li RA
    Mol Pharm; 2011 Oct; 8(5):1495-504. PubMed ID: 21879736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The Role of Large Animal Models in Cardiac Regeneration Research Using Human Pluripotent Stem Cell-Derived Cardiomyocytes.
    Cheng YY; Hu YF; Hsieh PC
    Curr Cardiol Rep; 2023 May; 25(5):325-331. PubMed ID: 37074564
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.